Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT03336593
Status:
COMPLETED
Last Update Posted:
2019-04-02
First Post:
2017-11-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population
Sponsor:
PT Bio Farma
Organization:
Study Overview
Official Title:
A Bridging Study to Assess Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is to assess protectivity and safety of Quadrivalent Influenza Vaccine in Indonesian Population
Detailed Description:
To describe the protectivity rate of Quadrivalent Influenza HA vaccine 28 days after immunization in Indonesian population.
To describe immunogenicity of quadrivalent Influenza HA vaccine in all subjects
To describe immunogenicity of quadrivalent Influenza HA vaccine in all subjects
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: